Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$209.01 - $232.56 $1.17 Million - $1.3 Million
-5,607 Reduced 5.19%
102,460 $22.4 Million
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $51,597 - $59,322
-261 Reduced 0.24%
108,067 $24.6 Million
Q3 2023

Feb 15, 2024

SELL
$201.05 - $221.7 $308,812 - $340,531
-1,536 Reduced 1.41%
107,498 $21.6 Million
Q2 2023

Feb 15, 2024

SELL
$211.93 - $241.33 $4.43 Million - $5.05 Million
-20,911 Reduced 16.09%
109,034 $26.3 Million
Q2 2023

Jul 28, 2023

SELL
$211.93 - $241.33 $9.53 Million - $10.9 Million
-44,990 Reduced 29.34%
108,328 $26.1 Million
Q1 2023

Feb 14, 2024

BUY
$213.32 - $257.83 $5.25 Million - $6.35 Million
24,616 Added 19.05%
153,831 $35.3 Million
Q1 2023

May 04, 2023

BUY
$213.32 - $257.83 $5.01 Million - $6.06 Million
23,509 Added 18.11%
153,318 $35.2 Million
Q4 2022

Feb 14, 2024

BUY
$203.72 - $248.97 $2.75 Million - $3.36 Million
13,509 Added 11.68%
129,215 $30.4 Million
Q3 2022

Feb 15, 2024

BUY
$204.81 - $262.19 $4.48 Million - $5.74 Million
21,878 Added 20.24%
129,945 $26.6 Million
Q3 2022

Nov 08, 2022

BUY
$204.81 - $262.19 $2.92 Million - $3.74 Million
14,268 Added 12.35%
129,809 $26.6 Million
Q2 2022

Feb 14, 2024

SELL
$213.86 - $277.87 $4.48 Million - $5.82 Million
-20,963 Reduced 15.34%
115,706 $27.1 Million
Q2 2022

Jul 26, 2022

SELL
$213.86 - $277.87 $4.52 Million - $5.87 Million
-21,128 Reduced 15.46%
115,541 $27.1 Million
Q1 2022

Feb 14, 2024

SELL
$259.82 - $298.18 $26 Million - $29.8 Million
-99,930 Reduced 42.24%
136,669 $36 Million
Q1 2022

May 06, 2022

SELL
$259.82 - $298.18 $26 Million - $29.8 Million
-99,930 Reduced 42.24%
136,669 $36 Million
Q4 2021

Feb 14, 2024

BUY
$271.6 - $314.21 $34.9 Million - $40.4 Million
128,532 Added 118.94%
236,599 $74.3 Million
Q4 2021

Feb 03, 2022

BUY
$271.6 - $314.21 $2.2 Million - $2.54 Million
8,086 Added 3.54%
236,599 $74.3 Million
Q3 2021

Nov 10, 2021

SELL
$274.82 - $308.34 $1.77 Million - $1.98 Million
-6,434 Reduced 2.74%
228,513 $64.3 Million
Q2 2021

Aug 11, 2021

SELL
$251.87 - $278.14 $7.81 Million - $8.63 Million
-31,026 Reduced 11.67%
234,947 $64.8 Million
Q1 2021

Apr 26, 2021

BUY
$204.88 - $255.03 $285,397 - $355,256
1,393 Added 0.53%
265,973 $67.8 Million
Q4 2020

Feb 10, 2021

BUY
$186.91 - $214.42 $17.8 Million - $20.4 Million
95,030 Added 56.05%
264,580 $53.9 Million
Q3 2020

Oct 28, 2020

BUY
$167.03 - $201.3 $9.9 Million - $11.9 Million
59,274 Added 53.75%
169,550 $31.9 Million
Q2 2020

Aug 10, 2020

BUY
$113.31 - $182.44 $1.54 Million - $2.48 Million
13,597 Added 14.06%
110,276 $18.3 Million
Q1 2020

May 04, 2020

SELL
$104.32 - $195.28 $2.93 Million - $5.49 Million
-28,111 Reduced 22.53%
96,679 $12.2 Million
Q4 2019

Feb 11, 2020

SELL
$163.48 - $173.61 $435,510 - $462,497
-2,664 Reduced 2.09%
124,790 $21.1 Million
Q3 2019

Nov 07, 2019

BUY
$159.77 - $178.1 $6.32 Million - $7.04 Million
39,546 Added 44.99%
127,454 $21.4 Million
Q2 2019

Jul 30, 2019

BUY
$144.16 - $172.9 $140,267 - $168,231
973 Added 1.12%
87,908 $0
Q1 2019

May 10, 2019

SELL
$123.7 - $156.3 $1.23 Million - $1.55 Million
-9,943 Reduced 10.26%
86,935 $0
Q4 2018

Jan 31, 2019

BUY
$120.82 - $174.09 $4.58 Million - $6.6 Million
37,930 Added 64.34%
96,878 $12.2 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $2.77 Million - $3.12 Million
16,548 Added 39.03%
58,948 $0
Q2 2018

Aug 03, 2018

SELL
$160.33 - $189.41 $542,075 - $640,395
-3,381 Reduced 7.39%
42,400 $0
Q1 2018

May 09, 2018

SELL
$161.53 - $178.11 $2.44 Million - $2.7 Million
-15,132 Reduced 24.84%
45,781 $0
Q4 2017

Feb 07, 2018

SELL
$147.99 - $163.95 $5.31 Million - $5.88 Million
-35,862 Reduced 37.06%
60,913 $0
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $14.5 Million - $15.5 Million
96,775
96,775 $0

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.